Ankylosing Spondylitis Clinical Trials

A listing of Ankylosing Spondylitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Glendale Arizona 85306

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

UPDATED

Peoria Arizona 85381

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

UPDATED

Phoenix Arizona 85032

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

View More ▼

UPDATED

Phoenix Arizona 85037

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

UPDATED

Tucson Arizona 85724

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

California

UPDATED

Fremont California 94538

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

UPDATED

Huntington Beach California 92648

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Huntington Beach California 92648

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Palm Desert California 92260

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Palm Desert California 92260

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Colorado

UPDATED

Colorado Springs Colorado 80920

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Colorado Springs Colorado 80920

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Denver Colorado 80230

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Denver Colorado 80230

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Connecticut

UPDATED

Danbury Connecticut 06810

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Danbury Connecticut 06810

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Trumbull Connecticut 06611

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

Florida

UPDATED

Aventura Florida 33180

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Palm Harbor Florida 34684

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Sarasota Florida 34239

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Sarasota Florida 34239

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

St. Petersburg Florida 33705

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

View More ▼

UPDATED

Tampa Florida 33614

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Georgia

UPDATED

Marietta Georgia 30060

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

Idaho

UPDATED

Idaho Falls Idaho 83404

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Idaho Falls Idaho 83404

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Meridian Idaho 83642

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Illinois

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Indiana

UPDATED

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Kentucky

UPDATED

Elizabethtown Kentucky 42701

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Elizabethtown Kentucky 42701

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Louisiana

UPDATED

Monroe Louisiana 71203

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

Maryland

UPDATED

Cumberland Maryland 21502

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Cumberland Maryland 21502

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Hagerstown Maryland 21740

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Hagerstown Maryland 21740

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Missouri

UPDATED

St. Louis Missouri 63141

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

St. Louis Missouri 63141

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Montana

UPDATED

Kalispell Montana 59901

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

Nebraska

UPDATED

Lincoln Nebraska 68516

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

New York

UPDATED

Albany New York 12203

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Albany New York 12203

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Orchard Park New York 14127

Patients are needed to participate in a clinical research study of Placebo, Ustekinumab 45 mg, Ustekinumab 90 mg and Golimumab 50 mg to evaluate Axial Spondyloarthritis, Anti-TNF(Alpha)

North Carolina

UPDATED

Raleigh North Carolina 27617

A clinical research study of Ixekizumab, Placebo and Adalimumab for the treatment of Spondyloarthritis

UPDATED

Raleigh North Carolina 27617

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

UPDATED

Wilmington North Carolina 28401

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis

Oregon

UPDATED

Portland Oregon 97239

Patients are needed to participate in a clinical research study evaluating Ixekizumab and Placebo for the treatment of Spondyloarthritis